Ophthalmology of the Near Future
Showcasing technologies that promise to transform the near future of your practice
Ophthalmology is in constant evolution, driven forward by pioneering practitioners and supported by forward facing businesses that are looking to find new ways of delivering better outcomes to patients and meeting unmet needs.
Ophthalmology of the Near Future is a digital program developed to provide the widest possible access to education about technologies and techniques that will drive the near future of ophthalmology.
The Light Adjustable Lens (RxSight)
Hunter Newsom presents the Light Adjustable Lens (LAL) from RxSight and explains how it is changing the way cataract surgery is performed and how truly customized vision is now a reality.
Photobiomodulation (LumiThera Inc.)
Clark Tedford and Eleonora Lad take us through an in-office, multi-wavelength device that improves vision and slows the progression of acute and chronic eye diseases such as dry AMD, diabetic retinopathy and macular edema, Stargardt’s disease and glaucoma.
The LumiThera technology suite is empowering doctors to provide state of the art care to their most challenging patients.
The OkuStim System (Okuvision)
Jens Schaumann demonstrates how their innovation is having an immediate significant impact on the treatment pathway for inherited retinal dystrophies (IRDs). Theirs is a treatment option for the currently incurable ocular disease retinitis pigmentosa and will be expanded into other degenerative eye conditions, in the future.
OkuVision’s technology is taking the pressure off primary and secondary care facilities within the treatment pathway and their goal is to provide access to care as the norm for patients with IRDs.
The VisioLite® Ophthalmic Laser System(AceVision)
AnnMarie Hipsley presents the VisioLite Ophthalmic Laser system and microporation therapeutics, which is a new field in ophthalmology.
The first therapy developed in the company’s series is laser scleral microporation (LSM) to address ocular rigidity or cross-linking of the sclera that occurs with age.
LSM is the only non-invasive therapeutic solution that addresses the real problem of presbyopia, introducing “uncross-linking” for the first time to destruct the compressive forces of cross-linking and the accompanying biomechanical stiffness.
TrabEx Pro (Micro Surgical Technology)
Erik Bror Bonn presents the TrabEx Pro system and outlines how this innovative MIGS device addresses many of the typical difficulties in performing glaucoma surgery.
Discover how TrabEx Pro improves intraoperative visibility and access to the natural outflow pathway. We also hear how the technology takes advantage of an intuitive surgical technique and improves OR workflow for doctors addressing glaucoma.
